Skip to content
Search

Latest Stories

NHS England awards £8.5m FDP contract to KPMG

NHS England awards £8.5m FDP contract to KPMG

Controversy sparked in November 2023 when NHS England awarded a £330 million contract for the FDP to US spy tech company Palantir 

NHS England has awarded an £8.5 million contract to consultancy firm KPMG "for technical support and implementation services" to help Integrated Care Boards (ICB) and NHS trusts in England to implement the Federated Data Platform (FDP) software.

According to the contract details published on Friday 12 April, KPMG "will support the NHSE Data Services team to not only build the Federated Data Platform (FDP) capability, but enhance the Data Service functions, platforms and integrating services to support the transformation change."


During the contract, which will extend until 17 March 2026, Additionally, the consultancy firm will assist ICBs and trusts in implementing their individual federated platforms, which will in turn feed into the national model.

NHSE ignited controversy in November 2023 when it granted a £330 million FDP contract to the US spy tech company Palantir, with concerns raised regarding the opaque nature of the tender process and the security of patient medical records.

On 22 December, NHS England published a heavily redacted version of its 586-page contract with Palantir to operate the platform.

After facing legal action from the Good Law Project, NHSE announced in March that it would republish its patient data contracts with Palantir with reduced redactions.

The legal campaign group also challenged NHS England over the extensive redactions in its contract with the bio-tech company IQVIA, which was awarded a £28m deal to provide “privacy enhancing technology” for the platform.

The Federated Data Platform software will enable NHS organisations to bring together operational data currently stored in separate systems, such as the number of beds in a hospital, the size of waiting lists for elective care services, or the availability of medical supplies, to support staff to access the information they need in one safe and secure environment.

NHSE has said that the FDP “will make it easier for staff at NHS trusts and integrated care boards (on behalf of integrated care systems (ICS) to access the information they need, freeing up valuable time to reinvest in delivering the best care possible for patients.”

“In the future, it will also enable Trusts and ICSs to make better use of the information they hold, supporting them to work together to understand patterns, solve problems, and plan services for their local populations,” it said.

As announced by the health service earlier, the implementation of the FDP will occur in stages spanning the next three years, beginning the transition phase from March to July 2024, followed by the delivery phase from May 2024 to March 2027. Once the transition phase proves successful, it will be gradually rolled out to new trusts and ICBs.

More For You

 RPS honours Professor Tony Avery OBE for excellence in prescribing safety and patient care

Professor Tony Avery OBE

Pic credit: RPS

Professor Tony Avery OBE awarded RPS Honorary Fellowship

The Royal Pharmaceutical Society (RPS) Assembly has awarded an Honorary Fellowship to Professor Tony Avery OBE in recognition of his outstanding contribution to prescribing safety and patient care.

The Honorary Fellowship is given to those who are not eligible for membership of the Society but have either attained a distinction in a particular aspect or aspects of pharmacy, made a distinctive contribution to pharmacy or the RPS, distinguished themselves in any branches of knowledge referred to in the objects of the Society or achieved eminence in public life.

Keep ReadingShow less
US-UK pharmaceutical trade concerns as Liberal Democrat MPs urge protection from Trump tariffs.

UK prime minster Sir Keir Starmer with US president Donald Trump

Pic credit: Getty images

Pharma sector needs protecting from Trump tariffs, warn MPs

A group of Liberal Democrat MPs have written to health secretary Wes Streeting urging him to protect the pharmaceutical industry from US president Donald Trump’s trade war.

The five ministers from Oxfordshire, Olly Glover, Layla Moran, Calum Miller, Charlie Maynard, and Freddie van Mierlo, have warned that Trump’s campaign to raise tariffs has already led to “catastrophic damage”.

Keep ReadingShow less
Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less